CTA
MRNA icon

Colonial Trust Advisors’s Moderna MRNA Stock Holding History

Colonial Trust Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$1.29K – 729
2025
Q3 		$1.29K Buy
+50
New +$1.4K ﹤0.01% 633
2024
Q2 		– Sell
-7
Closed -$746 – 934
2024
Q1 		$746 Sell
7
-10
-59% -$1.01K ﹤0.01% 882
2023
Q4 		$1.69K Buy
17
+14
+467% +$1.18K ﹤0.01% 727
2023
Q3 		$310 Sell
3
-7
-70% -$781 ﹤0.01% 851
2023
Q2 		$1.22K Sell
10
-9
-47% -$1.2K ﹤0.01% 782
2023
Q1 		$2.92K Sell
19
-4
-17% -$660 ﹤0.01% 684
2022
Q4 		$4.13K Buy
+23
New +$3.76K ﹤0.01% 644

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Colonial Trust Advisors's MRNA Position: Q4 2025 in Review

Colonial Trust Advisors sold out of Moderna (MRNA) in Q4 2025, closing a stake of 50 shares — an estimated $1.29K sold.

Colonial Trust Advisors first reported a position in MRNA in Q4 2022 and held it in 7 quarters. The position peaked at $4.13K in Q4 2022. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Colonial Trust Advisors reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Colonial Trust Advisors sold 50 Moderna shares in Q4 2025, an estimated $1.29K.
  • Colonial Trust Advisors first reported a position in Moderna in Q4 2022 and held it in 7 quarters.
  • Colonial Trust Advisors's Moderna position peaked at $4.13K in Q4 2022.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Colonial Trust Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.